Sustainability Investment in Life Sciences: Press Releases

IFA Capital Management, a new life sciences hedge fund launched by industry veterans Kellie Seringer and Matt Johnson, has announced a strategic partnership with Rho Impact for sustainability data tools. This collaboration will enhance IFA Capital's investment firm news as they leverage Rho's expertise in climate impact forecasting to support a concentrated investment strategy within the life sciences sector. Rho will provide Koi, the world’s most comprehensive data platform for assessing the impact potential of emerging sustainability solutions and their market opportunities, thereby strengthening IFA Capital’s ability to evaluate investments in low-carbon, industry-specific solutions. 

Research from the National Center for Biotechnology Information indicates that laboratories consume more energy per square meter than any other sector. As global climate regulations are implemented, this partnership will assist IFA Capital in identifying companies that offer superior market value and clinical outcomes while reducing energy, material use, and emissions compared to traditional market offerings. As the world shifts to a low-carbon economy, IFA Capital plans to utilize Koi to invest in the most promising medical breakthroughs. 

The IFA team’s extensive experience provides capital allocators with a unique opportunity to advance medical innovation aligned with a low-carbon economy. “Sustainability is becoming a measurable marker of company quality in life sciences—enhancing R&D efficiency, de-risking operations, and strengthening market positioning—while driving valuation premiums during M&A and IPO inflection points,” stated Kellie Seringer, Co-Founder and Portfolio Manager at IFA Capital. “Our collaboration with Rho Impact integrates sustainability into our due diligence, equipping portfolio companies to build higher-quality, future-ready operations that resonate with investors and leading pharmaceutical acquirers.” 

“Rho Impact is excited to partner with IFA Capital to accelerate sustainable innovation in this critical global sector,” said Noah Miller, Co-Founder & Chief Advisory Officer of Rho Impact. “As governments worldwide establish decarbonization goals for their healthcare systems, we believe IFA Capital will play a vital role in identifying, funding, and scaling impactful solutions in life sciences. We are proud to support IFA Capital’s important efforts.” 

About IFA Capital Management, LLC: IFA Capital Management, LLC is a specialized investment management firm focused on the life sciences sector. Founded by Kellie Seringer and Matt Johnson, who have over 50 years of combined experience in healthcare capital markets and clinical operations, the firm employs a disciplined, research-intensive framework to navigate the biotechnology landscape. 

About Rho Impact: Rho Impact is a leader in forecasting the effectiveness of emerging climate solutions. Since 2017, Rho has pioneered methodologies, tools, and data infrastructure that empower today’s global climate investment ecosystem. Koi (www.koi.eco) is the culmination of this work: the world’s only AI-driven platform designed to forecast the decarbonization potential of over 10,000 climate solutions across various industry applications, asset classes, and future market scenarios. This allows investors to analyze the future impact of their decision-making at any scale, from individual investments to global, multi-asset class portfolios. Trusted by institutional investors and asset managers worldwide, Rho Impact helps the field confidently direct capital towards the most credible climate solutions. Learn more at www.rhoimpact.com.